The Microdose | Substack

This Week in Psychedelics

A weekly round-up of psychedelic news.

New Top Community

Plus: Barriers to vets seeking psychedelic-assisted therapy, and 2022 in review

Jan 27

Plus: Results from psychedelic brain imaging feasibility study and gaining clarity on perennial psychedelic research issues

Jan 20

Plus: Psilocybin and depression, Oregon, and Prince Harry

Jan 13

Plus: Quebec pays for psilocybin therapy, and Indigenous ethical principles to guide Western psychedelic research

Jan 6

Plus: Boom and busts of shroom stores and Health Canada releases guidance on psychedelic trials

Dec 16, 2022

Plus: DEA releases final 2023 drug quotas and Berkeley resolution could decriminalize psychedelics

Dec 9, 2022

Plus: Ayahuasca’s adverse effects, and new details on why the UK rejected Spravato

Dec 2, 2022

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts